BYETTA

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Cyprus, Estonia, Finland, France, Ireland, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, South Africa, Spain, Turkey, UK.

Active ingredients

The drug BYETTA contains one active pharmaceutical ingredient (API):

1	Exenatide UNII 9P1872D4OL - EXENATIDE
	Exenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that exhibits several antihyperglycaemic actions of glucagon-like peptide-1 (GLP-1). The amino acid sequence of exenatide partially overlaps that of human GLP-1. Exenatide has been shown to bind to and activate the known human GLP-1 receptor in vitro, its mechanism of action mediated by cyclic AMP and/or other intracellular signalling pathways. Exenatide increases, on a glucose-dependent basis, the secretion of insulin from pancreatic beta cells.
	Read more about Exenatide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BYETTA Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BJ01	Exenatide	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BJ Glucagon-like peptide-1 (GLP-1) analogues
Discover more medicines within A10BJ01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	3423E, 3424F
BR	Câmara de Regulação do Mercado de Medicamentos	502317100031717, 502317100031817, 505115010021304
CA	Health Products and Food Branch	02361809, 02361817
EE	Ravimiamet	1270437, 1270448, 1270459, 1270460
ES	Centro de información online de medicamentos de la AEMPS	06362001, 06362003
FI	Lääkealan turvallisuus- ja kehittämiskeskus	072978, 072996
FR	Base de données publique des médicaments	60983726, 69937274
GB	Medicines & Healthcare Products Regulatory Agency	114949, 114956, 299809, 367636, 374327, 377165, 380743, 381237, 381239
JP	医薬品医療機器総合機構	2499411G1026, 2499411G2022
LT	Valstybinė vaistų kontrolės tarnyba	1005474, 1005475, 1027772, 1027774
NL	Z-Index G-Standaard	15612511, 15990362
NL	Z-Index G-Standaard, PRK	92916, 92932
NZ	Medicines and Medical Devices Safety Authority	12288, 12298
PL	Rejestru Produktów Leczniczych	100173861, 100173878
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W61681001, W61681002, W61682001, W61682002
TR	İlaç ve Tıbbi Cihaz Kurumu	8699786951006, 8699786952003
US	FDA, National Drug Code	0310-6512, 0310-6524
ZA	Health Products Regulatory Authority	41/34/0068, 41/34/0069